Regulatory Affairs Certification (RAC) Practice Exam

Disable ads (and more) with a membership for a one time $2.99 payment

Study for the RAC Exam. Study with flashcards and multiple choice questions, each question has hints and explanations. Get ready for your certification!

Each practice test/flash card set has 50 randomly selected questions from a bank of over 500. You'll get a new set of questions each time!

Practice this question and more.


An Investigational New Drug Application goes inactive when which of the following occurs?

  1. No subjects are entered for two years

  2. IND is put on clinical hold for one year

  3. Both of the above

  4. None of the above

The correct answer is: Both of the above

An Investigational New Drug Application (IND) goes inactive under specific circumstances that reflect a lack of progress in the clinical study or issues that prevent it from moving forward. One key scenario is when no subjects are entered into the clinical trial for a period of two years. This inactivity indicates that the study has stalled, which could lead regulatory authorities to consider the IND no longer in use. Additionally, if the IND is placed on a clinical hold for a continuous period of one year, that also contributes to its inactive status. A clinical hold may occur for various reasons, such as safety concerns or deficiencies in the study design, and if no resolution or progress is made within that timeframe, the IND is designated as inactive. Consequently, both scenarios—no subjects being entered for two years and being on clinical hold for one year—are valid reasons for an IND to be considered inactive. This makes the chosen answer correct, as it encompasses the two situations that lead to the inactivity of an Investigational New Drug Application.